Paroxetine versus clomipramine in adolescents with severe major depression: A double-blind, randomized, multicenter trial

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 42, Issue 1, 2003, Pages 22-29

  Braconnier, Alain ^a   Le Coent, Rémi ^b   Cohen, David ^c  

^a Centre Philippe Paumelle   (France)

^b GLAXOSMITHKLINE   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Adolescence; Clomipramine; Depression; Paroxetine

Indexed keywords

CLOMIPRAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; ANXIETY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FREQUENCY ANALYSIS; HEADACHE; HUMAN; HYPOTHESIS; INSOMNIA; IRRITABILITY; MAJOR DEPRESSION; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; TREMOR; XEROSTOMIA; CHILD; COMPARATIVE STUDY; FEMALE; MALE; MULTICENTER STUDY; NONPARAMETRIC TEST; PATIENT COMPLIANCE; SAFETY; STATISTICAL MODEL;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CHILD; CLOMIPRAMINE; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LOGISTIC MODELS; MALE; PAROXETINE; PATIENT COMPLIANCE; SAFETY; SEROTONIN UPTAKE INHIBITORS; STATISTICS, NONPARAMETRIC;

EID: 0037208894     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-200301000-00007     Document Type: Article

References (23)

1. American Academy of Child and Adolescent Psychiatry (1998), Practice parameters for assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 37(suppl):63S-83S
2. American Psychiatric Association (1994), Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). Washington, DC: American Psychiatric Association
3. Birmaher B, Brent DA, Kolko D et al (2000), Clinical outcome after short-term psychotherapy for adolescents with major depressive disorder. Arch Gen Psychiatry 57:29-36
4. Birmaher B, Ryan ND, Williamson DE et al. (1996), Childhood and adolescent depression: a review of the past 10 years, part I. J Am Acad Child Adolesc Psychiatry 35:1427-1439
5. Birmaher B, Waterman GS, Ryan ND et al. (1998), Randomized, controlled trial of amitriptyline versus placebo for adolescents with treatment-resistant major depression. J Am Acad Child Adolesc Psychiatry 37:527-535
6. Black IB, Handry LA, Iversen LL (1971), Trans-synaptic regulation of growth and development of adrenergic neurons in a mouse sympathetic ganglion. Brain Res 24:229-240
7. Brent DA, Holder D, Kolko D et al. (1997), A clinical psychotherapy trial for adolescent depression comparing cognitive, family and supportive treatments. Arch Gen Psychiatry 54:877-885
8. Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L (1974), The Hopkins Symptom Checklist (HSCL): a measure of primary symptom dimensions. Mod Probl Pharmacopsychiatry 7:79-110
9. Emslie GJ, Rush J, Weinberg WA et al. (1997), A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 54:1031-1037
10. Flament M, Cohen D (2000), Childhood obsessive-compulsive disorders. In: Obsessive-Compulsive Disorder: Evidence and Practice, Maj M, Sartorius N, eds. Geneva: World Psychiatric Association, pp 147-183
11. Geller B, Reising D, Leonard HL, Riddle MA, Walsh BT (1999), Critical review of tricyclic antidepressant use in children and adolescents. J Am Acad Child Adolesc Psychiatry 38:513-516
12. Godman-Rakic CP, Brown RM (1982), Postnatal development of monoamine content and synthesis in the cerebral cortex of Rhesus monkeys. Dev Brain Res 2:31-45
13. Guy W (1976), ECDEU Assessment Manual for Psychopharmacology. Bethesda, MD: National Institute of Mental Health
14. Hamilton M (1960), A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62
15. Keller MB, Ryan ND, Strober M et al. (2001), Efficacy of paroxetine in the treatment of adolescent major depression: a randomized controlled trial. J Am Acad Child Adolesc Psychiatry 40:762-772
16. Martin A, Kaufman J, Charney D (2000), Pharmacotherapy of early-onset depression: update and new directions. Child Adolesc Psychiatr Clin N Am 9:135-157
17. McTavish D, Benfield P (1990), Clomipramine: an overview of its pharmacological properties and a review of its therapeutic use in obsessive-compulsive disorder and panic disorder. Drugs 39:136-153
18. Milin R, Simeon J, Spenst W (1999), Double-blind study of paroxetine in adolescents with unipolar major depression. Presented at the American Academy of Child and Adolescent Psychiatry and Canadian Academy of Child Psychiatry Joint Annual Meeting, Chicago, October
19. Montgomery SA, Asberg M (1979), A new depression rating scale designed to be sensitive to change. Br J Psychiatry 134:382-389
20. Mufson L, Weissman MM, Moreau D, Garfinkel R (1999), Efficacy of interpersonal psychotherapy for depressed adolescents. Arch Gen Psychiatry 56:573-579
21. Ravindran AV, Judge R, Hunter BN, Bray J, Morton NH, for the Paroxetine Study Group (1997), A double-blind, multicencer study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. J Clin Psychiatry 58:112-118
22. Simeon JC, Dinicola VF, Ferguson BH, Copping W (1990), Adolescent depression: a placebo-controlled fluoxetine study and follow-up. Prog Neuropsychopharmacol Biol Psychiatry 14:791-795
23. Weissman MM, Wolk S, Goldstein RB et al. (1999), Depressed adolescents grown up. JAMA 281:1707-1713